Baskent University Medical Faculty Obstetric and Gynecelogy Department, Infertility and IVF unit
Adana, 01120, Turkey (Türkiye)
NCT Number: NCT00993902
Our hypothesis is double insemination will improve pregnancy rates in coh cycles with more than one dominant follicles (>16mm).
Looking for future studies?
Notify Me20 year–37 year
Female
Interventional
Phase 4
Adana, 01120, Turkey (Türkiye)
Metaanalysis for the effects of double IUI demonstrates that effects of this procedure is not different from single IUI. It is known that nearly 25% of coh cycles is evident by monofollicular development.For this reason it is possible that this monofollicular cycles in the studies could decrease the effects of double IUI.
Inclusion criteria
Primary outcome:
Ongoing pregnancy rates
Secondary outcomes:
The effects of different coh regimens (CC,FSH,CC+FSH)on the outcomes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Single IUI after 36-38 hours of HCG
Other names: Group I
Double insemination after 18 and 40 hours of HCG administration.
Other names: Grup II
Time frame: pregnancy >12 weeks of gestation
Time frame: 14 days after IUI procedure
Baskent University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06659692
Genital Diseases, Infertility
Toronto, Ontario, Canada
View Trial DetailsNCT06924437
Abnormal Uterine Bleeding (AUB), Endometrial Polyp
Sohag, Egypt
View Trial DetailsNCT01511588
Adolescents, Amenorrhea
Bethesda, Maryland, United States
View Trial DetailsNCT07399535
Adnexal Diseases, Cysts
Karachi, Sindh, Pakistan
View Trial Details